Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PACTR202407476433553Recruiting
Randomised, open-label trial of ciprofloxacin in incomplete spontaneous abortion (2 arms), sponsored by Federal Medical Centre Gusau. Primary endpoint: Post-abortion sepsis. Started Jul 2023; status: recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on PACTR202407476433553.